Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose
Open Access
- 1 June 1998
- Vol. 82 (11), 2227-2234
- https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- 18-fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant gliomaCancer, 1997
- Angiogenesis as a Predictor of Long-term Survival for Patients With Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Positron emission tomography: 2-deoxy-2-Z18F]-fluoro-d-glucose uptake in locally advanced breast cancersEuropean Journal of Surgical Oncology, 1995
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- Novel growth regulatory factors and tumour angiogenesisEuropean Journal of Cancer and Clinical Oncology, 1991
- Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancerJournal of Steroid Biochemistry, 1987
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- Prediction of survival in glioma patients by means of positron emission tomographyJournal of Neurosurgery, 1985
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- On the Origin of Cancer CellsScience, 1956